Trazodone is not a true anticholinergic. It has extremely weak binding to muscarinic receptors, the receptors responsible for anticholinergic side effects like dry mouth, constipation, and blurred vision. Its anticholinergic activity is estimated to be 150 to 800 times weaker than that of tricyclic antidepressants like amitriptyline and imipramine.
How Trazodone Actually Works
Trazodone is classified as a serotonin antagonist and reuptake inhibitor (SARI). It works primarily by blocking certain serotonin receptors and, at higher doses, preventing serotonin from being reabsorbed by nerve cells. It also blocks receptors for adrenaline (which can cause dizziness upon standing) and histamine (which contributes to its sedating effect).
At low doses, like the 25 to 50 mg commonly prescribed for sleep, trazodone’s main actions are blocking serotonin receptors (97% occupancy), adrenaline receptors (88%), and histamine receptors (84%). It doesn’t significantly block serotonin reuptake until doses reach 100 to 150 mg, which is why higher doses are needed for treating depression.
Its Muscarinic Receptor Activity Is Negligible
Anticholinergic effects come from blocking muscarinic acetylcholine receptors in the brain and body. Trazodone barely touches these receptors at any dose. A pharmacological study published in the Journal of Psychopharmacology calculated that even at 150 mg per day, trazodone occupies less than 0.25% of muscarinic receptors. At 50 mg, that number drops below 0.10%.
The researchers specifically noted that trazodone’s minimal muscarinic receptor activity makes it suitable for people with conditions that anticholinergic drugs can worsen, including glaucoma, certain heart conditions, prostate enlargement, chronic constipation, and dementia.
Why It Still Causes Dry Mouth
If trazodone isn’t anticholinergic, you might wonder why dry mouth is one of its most common side effects. In clinical trials, dry mouth occurred in about 15% of hospitalized patients and 34% of outpatients taking trazodone. Constipation showed up in about 7% of both groups, and blurred vision in 6 to 15%.
These symptoms look like anticholinergic effects, but they’re likely caused by trazodone’s action on other receptors, particularly its serotonin and adrenaline receptor blocking. Serotonin pathways influence salivary glands, and adrenaline receptor blockade can affect moisture production in mucous membranes. So the side effects overlap, but the mechanism behind them is different.
How It Compares to Drugs With Real Anticholinergic Load
A large review comparing trazodone to imipramine (a tricyclic antidepressant with strong anticholinergic properties) found that more than 50% of imipramine patients reported at least one anticholinergic side effect, compared to only 20% of those on trazodone. For each specific symptom, including dry mouth, blurred vision, bowel problems, and difficulty urinating, the rate in the imipramine group was two to three times higher.
On the Anticholinergic Cognitive Burden (ACB) scale, a tool used to assess how much a medication contributes to anticholinergic-related thinking problems, trazodone receives a score of 1 out of 3. A score of 1 means “possible” anticholinergic activity. For comparison, drugs considered definite anticholinergics, like older antihistamines, certain bladder medications, and tricyclic antidepressants, score 2 or 3. A score of 1 is the lowest possible positive rating on the scale, essentially a flag that some mild activity exists but is not clinically significant in most cases.
What This Means at Different Doses
Because trazodone’s muscarinic receptor occupancy stays well below 1% across all commonly used doses, the anticholinergic concern doesn’t meaningfully change whether you’re taking 25 mg for sleep or 150 mg for depression. This is unlike some other medications where anticholinergic burden increases sharply with dose. With trazodone, the receptors it occupies more aggressively at higher doses are serotonin transporters, not muscarinic receptors.
For people who need to avoid anticholinergic medications, whether due to cognitive concerns, glaucoma, urinary retention, or other reasons, trazodone is generally considered a safer choice than tricyclic antidepressants or many older antihistamines. Its ACB score of 1 still warrants awareness, particularly for older adults taking multiple medications that each carry a small anticholinergic load, since those effects can add up across a full medication list.